Tell us which new products made the most difference to your lab work and you’ll have the chance to win one of four $500 Amazon gift cards
Meet one of the first cryo-EM groups set on delivering a resolution revolution
Read how GSK’s Method Innovation team is evaluating new technologies to drive efficiency in biopharma molecule development, in this exclusive interview
From patient-derived organoids to virus-specific T cells, explore the latest techniques and technologies advancing the field of precision medicine
Discover the latest technologies and techniques that are revolutionizing microbiome research
Dr. John Connolly, CSO of Tessa Therapeutics, reveals how a new approach to cell-based therapy in cancer could circumvent severe immunotherapy side effects and effectively target aggressive solid tumors
Get up to date on hot topics in the drug discovery community in our latest monthly compilation of content highlights
Integrated package of new and established services saves time and minimizes risks
Complementary product portfolios will support and accelerate expansion into the pharmaceutical industry
Side effects are similar to injectable glucagon, with the addition of nasal and eye-related symptoms
Join this expert webinar to find out how imaging and true 3D high-content analysis can benefit drug studies based on patient-derived organoids
New partnership to advance Nosopharm’s lead candidate to clinical stage
Phase 1 trial scheduled for early 2020 will be first CAR-T cell therapy clinical trial to employ SMARTvector technology
inStem’s Centre for Chemical Biology and Therapeutics to work with PhoreMost to progress selected targets
Eisai enters into collaborative research agreement with University of Dundee
Discover a range of new technologies and applications for biopharmaceutical development in this special editorial feature
This new range of kits is said to deliver high-quality ChIP-ready chromatin from as little as 5 Drosophila specimens
Novel cyclic IMS and new SYNAPT XS lead Waters’ portfolio of solutions that promise unlimited experimental opportunities and analytical flexibility
As the global antibody market hits new heights, meet one scientist working to bridge the gap between biomarker discovery and antibody development with high-speed phage-display technology
Collaborative project has successfully demonstrated that aging in nematodes is partially programmed and can be modified therapeutically
Real-time, live-cell imaging and analysis tools for effective antibody characterization
The new collaborative project aims to explore the potential use of aptamers as treatment for myeloid malignancies
This new solution could enable large-scale AAV vector production for gene therapy
